hemotune AG
🇨🇭Switzerland
- Country
- 🇨🇭Switzerland
- Ownership
- Holding
- Established
- 2016-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.hemotune.ch
Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Not Applicable
1 (100.0%)First in Human Trial to Assess the Feasibility and Preliminary Safety of Adjunctive Treatment with the HemoSystem REBOOT in Critically Ill Patients with Sepsis-induced Immunosuppression
Not Applicable
Not yet recruiting
- Conditions
- Septic Shock
- First Posted Date
- 2024-02-14
- Last Posted Date
- 2025-03-14
- Lead Sponsor
- hemotune AG
- Target Recruit Count
- 16
- Registration Number
- NCT06258291
- Locations
- 🇨🇭
University Hospital Bern Inselspital, Bern, Switzerland
🇨🇭University Hospital Zurich, Zurich, Switzerland
News
No news found